A7502
DL-Alanine
≥99% (HPLC)
Synonyme(s) :
(±)-2-Aminopropionic acid
Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
Changer de vue
A propos de cet article
Formule linéaire :
CH3CH(NH2)COOH
Numéro CAS:
Poids moléculaire :
89.09
UNSPSC Code:
12352209
NACRES:
NA.26
PubChem Substance ID:
EC Number:
206-126-4
Beilstein/REAXYS Number:
1720250
MDL number:
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderQuality Level
assay
≥99% (HPLC)
form
powder
technique(s)
ligand binding assay: suitable
color
white to off-white
mp
289 °C (dec.) (lit.)
solubility
H2O: soluble
application(s)
peptide synthesis
SMILES string
CC(N)C(O)=O
InChI
1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)
InChI key
QNAYBMKLOCPYGJ-UHFFFAOYSA-N
Application
DL-Alanine, a racemic mixture of D- and L-alanine, is used as a model reagent for development of amino acid racemic resolution techniques. DL-Alanine is used in mixed ligand (chelate) studies with transition metals such as Cu(II), Zn(ll) and Cd(ll).
Classe de stockage
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Tatjana Braun et al.
Proceedings of the National Academy of Sciences of the United States of America, 112(30), 9340-9345 (2015-07-01)
The prokaryotic origins of the actin cytoskeleton have been firmly established, but it has become clear that the bacterial actins form a wide variety of different filaments, different both from each other and from eukaryotic F-actin. We have used electron
Randolph M Baral et al.
Journal of feline medicine and surgery, 17(8), 653-666 (2014-10-10)
In-house analysers are commonplace in small animal practices but cannot be calibrated by the operator; therefore, any bias in the generated plasma analyte values cannot be corrected. Guidelines such as grading of renal disease and published reference intervals (RIs) in
Janine Rohrbach et al.
Antiviral therapy, 19(2), 149-159 (2013-09-17)
We investigated changes in biomarkers of liver disease in HIV-HCV-coinfected individuals during successful combination antiretroviral therapy (cART) compared to changes in biomarker levels during untreated HIV infection and to HIV-monoinfected individuals. Non-invasive biomarkers of liver disease (hyaluronic acid [HYA], aspartate